• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

emids Acquires Healthcare Software Development Firm Macadamian

by Fred Pennic 01/28/2021 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print
emids Acquires Canadian Design-Led Software Engineering Firm Macadamian

What You Should Know:

– Healthcare IT company emids announced the acquisition of Canadian-based Macadamian, a global full-service healthcare software design and development consulting firm.  

– The acquisition reflects emids’ response to accelerated investment in digital health and provides it with a competitive advantage as the addition of design capabilities allows it to support the entire continuum of customers’ digital transformation efforts.

– A milestone in the company’s growth plan, the acquisition also expands emids’ presence into Canada and Eastern Europe and increases its personnel to more than 2,300, with the addition of 109 expert designers, developers and engineers.


emids,a Nashville, TN-based digital engineering and transformation solutions to the healthcare and life sciences industry, today announced the acquisition of  Canadian-based Macadamian, one of the largest and most respected healthcare specialist firms of its kind in the world. The acquisition marks another step in its purposeful growth strategy of adding global design-led software engineering capabilities.

Helping Clients Imagine the Future of Healthcare

Founded in 1997, Macadamian is a full-service software design and development consultancy, combining business strategy, user insights, and cutting-edge technological expertise to accelerate and bring to market breakthrough healthcare solutions. Macadamian clients include TELUS Health, Siemens Healthineers, Edwards, AMGEN, Fresenius Medical Care, and others.

emids has a strong track record of delivering complex solutions to its clients using its deep engineering and applications capabilities. The addition of Macadamian’s design-first capabilities is a perfect complement and will help both emids and Macadamian customers work with a single partner that brings in great depth and breadth in domain, design and engineering. 

“Our merger with emids is a superior match of entrepreneurial mindset, complementary skill sets and healthcare specialization, and we’re excited about what we’ll be able to achieve together for our customers and for healthcare at large,” said Macadamian CEO Frederic Boulanger. 

Post-Acquisition Impact

The Macadamian acquisition expands emids’ global employee footprint to more than 2,300, with 109 expert designers, developers and engineers in Canada and Eastern Europe. Macadamian’s clients run the gamut from early-stage to Fortune 500 companies with a heavy concentration in biopharmaceuticals and medical devices. Macadamian further expands emids’ IP, centers of excellence and platform capabilities, including its HealthConnect application development platform as a service, which has proven a powerful underlying architecture to accelerate the development of data-informed medical devices and digital therapeutic software applications for clients.

“Our customers have accelerated both their timelines and their investments in digital and virtual health solutions focusing on patients in the wake of COVID-19, and our acquisition of Macadamian very eloquently delivers the added sophistication that our payer, provider and life sciences partners need and demand when bringing to market digital solutions to transform the healthcare experience,” said emids Founder and CEO Saurabh Sinha. “Design has become an embedded part of the transformation value chain, and we were immediately struck by Macadamian’s design-first approach, its patented IP and innovations Lab and its sheer depth and breadth in the healthcare space.”

Financial terms of the acquisition, which closed earlier this month, were not disclosed. 


  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: digital health, digital transformation, healthcare it, Healthcare Mergers & Acquisitions, Life Sciences, Medical Devices, Partners, Siemens, Siemens Healthineers

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |